Persist AI logo

Persist AI

Developing long-lasting drug formulations 50% faster

Winter 2023Healthcare / Healthcare -> Drug Discovery and DeliveryWoodland, CA, USA6 employees
Machine Learning
Robotics
Microfluidics
Nanotechnology
Therapeutics

About

It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (2)

Christopher Shelner
Founder
Karthik Raman
Founder

Details

Status
Active
Stage
Growth
Team Size
6
Regions
United States of America, America / Canada, Remote, Partly Remote